GLUBRAVA

This brand name is authorized in Austria, Estonia, Ireland, Italy, Lithuania, Poland, Spain.

Active ingredients

The drug GLUBRAVA contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII JQT35NPK6C - PIOGLITAZONE HYDROCHLORIDE
 

Pioglitazone effects may be mediated by a reduction of insulin resistance. Pioglitazone appears to act via activation of specific nuclear receptors (peroxisome proliferator activated receptor gamma) leading to increased insulin sensitivity of liver, fat and skeletal muscle cells in animals. Treatment with pioglitazone has been shown to reduce hepatic glucose output and to increase peripheral glucose disposal in the case of insulin resistance.

 
Read more about Pioglitazone
2
UNII 786Z46389E - METFORMIN HYDROCHLORIDE
 

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

 
Read more about Metformin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A10BD05 Metformin and pioglitazone A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1364374, 1364385, 1364396, 1364408, 1364419, 1364420, 1364431, 1364442, 1364453
ES Centro de información online de medicamentos de la AEMPS 07421005
IT Agenzia del Farmaco 038529057
LT Valstybinė vaistų kontrolės tarnyba 1032543, 1032544, 1032545, 1032546, 1032547, 1032548, 1032549, 1032550, 1032551
PL Rejestru Produktów Leczniczych 100309869

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.